Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
U.S. stocks movement | Federal Medicare Advantage Plan ratings greatly improved, Humana (HUM.US) surged nearly 12%

U.S. stocks movement | Federal Medicare Advantage Plan ratings greatly improved, Humana (HUM.US) surged nearly 12%

智通财经智通财经2026/10/09 14:31
Show original

According to information from Zhitong Finance APP, on Friday, Humana (HUM.US) shares surged as much as 18% in early trading and were up nearly 12% at $433.07 at the time of reporting. Humana disclosed that 95% of relevant insured members have entered plans rated four stars or above. Based on the final Medicare Advantage Plan star ratings for 2027, Humana expects the average monthly star rating revenue per member to reach $160 by 2027. The company stated that this performance has exceeded its "top quartile" target, which is 10% higher than the industry average. Humana reaffirmed its guidance for adjusted earnings per share of at least $9 for fiscal year 2026.

智通财经APP has learned that on Friday, Humana (HUM.US) shares surged nearly 18% in early trading and, as of press time, were up nearly 12%, trading at $433.07. According to reports, Humana disclosed that 95% of its relevant insured members have entered four-star or higher plans. Based on the final star rating data for 2027 Medicare Advantage plans, Humana expects that by 2027, the average monthly star-related income per insured member will reach $160. The company stated that this performance has exceeded its "top quartile" target, meaning it is 10% above the industry average. Humana reaffirmed its guidance for adjusted earnings per share of at least $9 for fiscal year 2026.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. stocks move | Moderna (MRNA.US) rises 7% after being included in the Nasdaq 100 Index

According to information from Zhihui Finance APP, on Friday, Moderna (MRNA.US) surged as much as 10% during trading, reaching its highest share price since December 2022. As of press time, the gain narrowed to 7%, with the stock trading at $210.95. On the news front, on October 9, Moderna was officially included in the Nasdaq 100 index, replacing Warner Bros Discovery. After its inclusion, some broad-based institutions that previously did not allocate to biotech will now passively hold the stock, while active institutions will add the company to their watch lists, increasing attention on the individual stock.

智通财经•2026/10/09 15:56

FCC Chairman Carr expresses satisfaction with the progress of the Disney lawsuit

FCC Chairman Carr stated that he is "satisfied" with the progress of the lawsuit against Disney (DIS.US).

智通财经•2026/10/09 15:47

PDVSA says Venezuela’s oil production will reach 1.5 million barrels per day by the end of 2027

The head of Venezuela's state oil company PDVSA stated that Venezuela's oil production will reach 1.5 million barrels per day by the end of 2027.

智通财经•2026/10/09 15:46